Histone acetylation loosens chromatin structure, making DNA more accessible for gene activity. It does this by neutralizing the positive electrical charge on histone proteins, weakening their grip on negatively charged DNA. This single chemical change has cascading effects on how tightly DNA is packed, which genes get turned on, and how cells respond to their environment.
The Chemistry Behind Chromatin Loosening
DNA wraps around clusters of histone proteins like thread around a spool, forming units called nucleosomes. Histones carry a positive electrical charge on specific amino acids (lysines) in their protruding “tails.” That positive charge attracts the negatively charged DNA backbone, holding the whole structure tightly together.
When an acetyl group is attached to one of those lysine residues, it neutralizes the positive charge. This weakens both the histone-to-DNA and histone-to-histone interactions that keep nucleosomes compact. The result is increased DNA unwrapping and, in some cases, full nucleosome disassembly. Think of it like loosening the clamps on a coiled spring: the structure relaxes and the DNA becomes physically exposed.
One acetylation site with outsized importance is lysine 16 on histone H4 (H4K16). Acetylation here disrupts a specific contact point where the H4 tail binds to an “acidic patch” on neighboring nucleosomes. That interaction normally helps nucleosomes stack against each other to form a more condensed fiber. When H4K16 is acetylated, the tail becomes more flexible, inter-nucleosome stacking weakens, and the chromatin fiber opens up. This also frees the acidic patch surface for other regulatory proteins to bind.
Two Types of Chromatin, Defined by Acetylation
Chromatin exists on a spectrum between two states. Euchromatin is the open, gene-active form. Heterochromatin is the tightly packed, gene-silent form. Acetylation levels are one of the clearest markers distinguishing the two.
Antibody staining of chromosomes shows intense acetylation across euchromatic regions and much lower acetylation in heterochromatin. This pattern holds across species, from mammals to plants. In field bean chromosomes, for example, heterochromatin only picks up acetylation briefly during DNA replication in late S phase, then gets stripped of it well before the cell divides. Euchromatin, by contrast, maintains strong acetylation through much of the cell cycle, particularly during early and mid-S phase when it replicates. The cell essentially uses acetylation as a temporary pass: heterochromatin gets acetylated just long enough to replicate, then locks back down.
How Acetylation Switches Genes On
Loosening chromatin is only half the story. Acetylated histones also serve as landing pads for proteins that physically read the acetyl marks. Bromodomain proteins are the primary readers. They bind specifically to acetylated lysines on histone tails and anchor larger complexes to those sites. These complexes include chromatin remodelers, additional histone-modifying enzymes, and components of the transcription machinery itself. So acetylation doesn’t just open the door; it puts up a sign that recruits the workers.
This recruitment matters at both promoters (the launch sites for genes) and enhancers (distant regulatory switches that amplify gene activity). Experiments in neurons illustrate this vividly. When researchers artificially added acetylation to specific enhancers of the Fos gene (an activity-triggered gene in the brain), Fos messenger RNA levels increased significantly, both at rest and after the neurons were stimulated. Conversely, when they recruited a deacetylating enzyme to the same enhancer, Fos expression dropped.
The mechanism turns out to be surprisingly precise. Adding acetylation to an enhancer primarily increased how long the gene’s promoter stayed in the “on” state after switching on, extending each burst of transcription. Removing acetylation did the opposite: it reduced how often the promoter turned on in the first place, leaving it silent for longer stretches. Acetylation at the enhancer also helped recruit a bromodomain protein called Brd4, which promoted the release of stalled transcription machinery so the gene could be fully read. In other words, enhancer acetylation fine-tunes gene expression by adjusting both the frequency and duration of transcriptional bursts.
The Enzymes That Add and Remove Acetyl Marks
Two enzyme families control the balance. Histone acetyltransferases (HATs) attach acetyl groups to lysines. Histone deacetylases (HDACs) remove them. The system is fully reversible, which means acetylation patterns can shift rapidly in response to signals. Both enzyme families also modify non-histone proteins, giving them roles in cell function beyond chromatin regulation.
Several HAT enzymes, including GCN5, PCAF, CBP, p300, and TIP60, operate in the nucleus. They differ in which lysines they prefer and which gene programs they support, but they all require the same fuel: a small molecule called acetyl-CoA. This is the same molecule that sits at the center of energy metabolism, which creates a direct link between a cell’s metabolic state and its gene expression patterns.
Metabolism Sets the Pace of Acetylation
Acetyl-CoA freely diffuses into the nucleus, where it serves as the raw material for every acetylation reaction. When acetyl-CoA levels are high, HATs have more substrate to work with, and histone acetylation increases. When levels drop, acetylation slows.
This connection has real physiological consequences. During fasting or calorie restriction, the enzyme that produces cytoplasmic acetyl-CoA (ATP-citrate lyase) decreases in activity across tissues like skeletal muscle, heart, and fat. The resulting drop in acetyl-CoA reduces p300 HAT activity, which in turn lowers histone acetylation at specific gene targets. One downstream effect is the activation of autophagy, the cell’s recycling program. Compounds that lower cytoplasmic acetyl-CoA have been described as calorie restriction mimetics precisely because they reproduce this chain of events.
The relationship works in both directions. Increasing nuclear acetyl-CoA levels boosts histone acetylation, and administering HDAC inhibitors (which block acetyl group removal) increases acetylation and has been linked to longevity in experimental models. The cell, in effect, reads its own energy status through the acetylation marks on its chromatin.
What Happens When Acetylation Goes Wrong
Because acetylation controls which genes are accessible, disruptions to the system can drive disease. Cancer cells frequently show abnormal acetylation patterns, with tumor-suppressing genes improperly silenced and growth-promoting genes improperly activated. This has made HDACs a target for drug development. Four HDAC inhibitors (vorinostat, romidepsin, belinostat, and panobinostat) are FDA-approved for treating lymphoma, where they work by restoring acetylation to genes that cancer cells had silenced, reactivating programs for cell death and growth arrest.
The therapeutic logic is straightforward: if a cancer cell survives partly by deacetylating the wrong genes, blocking that deacetylation can re-expose those genes and push the cell toward death. The challenge is specificity, since HDACs affect thousands of targets across the genome and beyond, but the clinical results in blood cancers have been strong enough to support routine use.